Literature DB >> 24337342

[Pharmacokinetics of the anterior eye].

K Bell1, N Pfeiffer, F H Grus.   

Abstract

The pharmacokinetics of the anterior eye comprises the application, resorption, bioavailability, metabolization and elimination of topically administered drugs. In addition to the necessity of the penetration of the substance through the naturally occurring barriers of the eye in the form of the tear film, cornea, conjunctiva and sclera, the correct technique for administration is necessary for an optimal effect of the drug. Several new application devices have been described in the literature but most are still in an experimental phase. The main aims are to increase drug exposure time to the anterior surface of the eye and decrease problems in administration. Furthermore, new preservative agents are in use in order to produce less toxic side effects.

Mesh:

Substances:

Year:  2014        PMID: 24337342     DOI: 10.1007/s00347-013-2931-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  40 in total

Review 1.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

2.  Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

3.  Time course of changes in ocular wavefront aberration after administration of eye ointment.

Authors:  T Hiraoka; T Yamamoto; F Okamoto; T Oshika
Journal:  Eye (Lond)       Date:  2012-07-20       Impact factor: 3.775

4.  Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.

Authors:  M F Saettone; B Giannaccini; A Teneggi; P Savigni; N Tellini
Journal:  J Pharm Pharmacol       Date:  1982-07       Impact factor: 3.765

Review 5.  Allergic reaction to topical eyedrops.

Authors:  Christophe Baudouin
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-10

6.  Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.

Authors:  A Shedden; J Laurence; R Tipping
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

7.  Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.

Authors:  K D Kao; D W Lu; C H Chiang; H S Huang
Journal:  J Ocul Pharmacol       Date:  1990

8.  Intraocular ciprofloxacin levels after oral administration in silicone oil-filled eyes.

Authors:  Dinesh Talwar; Amol Kulkarni; RajVardhan Azad; Suresh K Gupta; T Velpandian; YogRaj Sharma; Nihar R Biswas
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

Review 9.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

10.  Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.

Authors:  Douglas G Day; Thomas R Walters; Gail F Schwartz; Thomas K Mundorf; Charlie Liu; Rhett M Schiffman; Marina Bejanian
Journal:  Br J Ophthalmol       Date:  2013-06-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.